A GUIDE TO THE INTERPRETATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS

被引：46
作者：
BUNTING, PS [1 ]
机构：
[1] UNIV TORONTO, SUNNYBROOK HLTH SCI CTR, DEPT LAB MED, TORONTO, ON, CANADA
来源：
CLINICAL BIOCHEMISTRY | 1995年 / 28卷 / 03期
关键词：
PROSTATE SPECIFIC ANTIGEN; PROSTATIC ACID PHOSPHATASE; REFERENCE RANGES; METABOLISM; ANALYSIS IN BLOOD; ANTIANDROGEN THERAPY; RADIATION THERAPY; RADICAL PROSTATECTOMY; INTRAINDIVIDUAL VARIATION; STAGE;
D O I：
10.1016/0009-9120(95)91342-Z
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Objectives: To review the factors that af feet the concentration of prostate specific antigen (PSA) In the serum. Results: The discussion includes the structure of PSA; its distribution and metabolism; various analytical aspects of PSA measurements; the effects of clinical manipulations on PSA, including digital rectal examination, transrectal ultrasound, cystoscopy, biopsy and transurethral resection of the prostate; factors affecting PSA levels in health, in benign disease, and in prostate cancer; the effect of various treatments on PSA; and the issue of reference ranges. Conclusion: Laboratory staff and physicians must take many factors into consideration when interpreting PSA results.
引用
收藏
页码：221 / 241
页数：21
相关论文
共 177 条
  • [1] Oesterling, Prostatic tumor markers, Urol Clin North Am, 20, pp. 1-794, (1993)
  • [2] Oesterling, Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate, J Urol, 145, pp. 907-923, (1991)
  • [3] Armbruster, Prostate-specific antigen: Biochemistry, analytical methods, and clinical application, Clin Chem, 39, pp. 181-195, (1993)
  • [4] Ploch, Brawer, How to use prostate-specific antigen, Urology, 43, pp. 27-35, (1994)
  • [5] Dorr, Williamson, Stephens, An evaluation of prostate-specific antigen as a screening test for prostate cancer, Arch Intern Med, 153, pp. 2529-2537, (1993)
  • [6] Catalona, Smith, Ratliff, Basler, Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening, JAMA, 270, pp. 948-954, (1993)
  • [7] Labrie, Dupont, Suburu, Et al., Optimized strategy for detection of early stage, curable prostate cancer: Role of prescreening with prostate-specific antigen, Clin Invest Med, 16, pp. 425-439, (1993)
  • [8] Kramer, Brown, Prorok, Potosky, Gohagan, Prostate cancer screening: What we know and what we need to know, Ann Intern Med, 119, pp. 914-922, (1993)
  • [9] Catalona, Richie, Ahmann, Et al., Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men, J Urol, 151, pp. 1283-1290, (1994)
  • [10] Krahn, Mahoney, Eckman, Trachtenberg, Pauker, Detsky, Screening for prostate cancer: A decision analytic view, JAMA, 272, pp. 773-780, (1994)
12345678910